Some major treatment guidelines currently recommend initiation when CD4 cells count drops below 350 cells/mm3 while others at CD4 cell count below 500 cells/mm3 or in all patients with diagnosed HIV infection (e.g. [1-4]). This evidence concerns the gene CD4 and HIV infectious disease.